Sort
16,300 grants matching “fatty liver disease”
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
$687,760David L Thomas · Johns Hopkins University · R01 · FY2022 · DA
MKP1, VSMC, and Vascular Remodeling
$687,739Ping Song · Georgia State University · R01 · FY2019 · HL
MKP1, VSMC, and Vascular Remodeling
$687,739Ping Song · Georgia State University · R01 · FY2021 · HL
MKP1, VSMC, and Vascular Remodeling
$687,739Ping Song · Georgia State University · R01 · FY2020 · HL
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors
$687,694Edward Giovannucci · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · CA
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
$687,581David L Thomas · Johns Hopkins University · R01 · FY2023 · DA
Animal Models for Studying the Genetics of Hypertension
$687,295Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2008 · HL
Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance
$687,224Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2022 · HL
Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites
$687,172Unhee Lim · University Of Hawaii At Manoa · R01 · FY2023 · MD
Liver-Gut-Microbiome Axis and Fatty acid absorption in Preterm Infants
$687,052Amy Boriskie Hair · Baylor College Of Medicine · R01 · FY2024 · DK
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)
$686,972Jason A Wertheim · University Of Arizona · R01 · FY2025 · DK
Shape up! Kids
$686,182John Alan Shepherd · University Of Hawaii At Manoa · R01 · FY2018 · DK
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
$685,984Anders M Naar · Massachusetts General Hospital · R01 · FY2012 · DK
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
$685,914D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression
$685,752Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2019 · DK
Nuclear receptors: action, functions, and roles in disease
$685,660Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Dietary Effects on Imaging and Fluid-based Biomarkers of the Adipose-Brain Axis in Alzheimers Disease
$685,342Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2021 · AG
Vervet Research Colony as a Biomedical Resource
$685,325Jay R Kaplan · Wake Forest University Health Sciences · P40 · FY2015 · OD
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
$685,269Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2017 · AI
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
$685,269Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2016 · AI
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
$685,245Arun J Sanyal · Virginia Commonwealth University · R01 · FY2017 · DK
Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes
$684,914Muhammad Abdul-Ghani · University Of Texas Hlth Science Center · R01 · FY2025 · DK